CATALIGO MAGNESIUM - D3 LIQ DIN 02121093
Health Canada record
| Active ingredient(s) | MAGNESIUM 3 D |
|---|---|
| Dosage form | Liquid |
| Route | Oral |
| Schedule | HOMEOPATHIC |
| Class | Human |
| ATC | |
| Original market date | 31-Dec-1986 |
| Current status date | 12-Jan-1998 |
| Source | Health Canada DPD |
Establishment licence of the holder
Laboratoires K.A.B.S. Inc. — licence 100681, currently licensed, last inspection rating C (2026-06-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MAGNESIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02241068 | FORMULA STATIN SUPPORT | BALANCE PLUS, INC. | Capsule | MAGNESIUM 200 MG; D-PANTOTHENIC ACID 50 MG; VITAMIN B6 (VITAMIN B6) 50 MG; VITAMIN B12 (VITAMIN B12) 50 MCG; UBIDECARENONE 30 MG | Cancelled Post Market |
| 02234042 | MAGNESIUM METALLICUM | HOMEOCAN INC. | Globules; Granules; Drops | MAGNESIUM 3 X | Cancelled Post Market |
| 02234596 | MAGNESIUM METALLICUM | DOLISOS CANADA INC. | Granules; Liquid; Globules | MAGNESIUM 3 X | Cancelled Post Market |
International API supply for MAGNESIUM
159 active FDA Drug Master Files.
Request a quote for CATALIGO MAGNESIUM - D3 LIQ